Comments: US SB4152 | 2021-2022 | 117th Congress
Bill Title: A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
Spectrum:
Status: (Introduced - Dead) 2022-05-05 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. [SB4152 Detail]
Text: Latest bill text (Introduced) [PDF]
Spectrum:
Status: (Introduced - Dead) 2022-05-05 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. [SB4152 Detail]
Text: Latest bill text (Introduced) [PDF]
PolitiCorps Conversations
Start PolitiCorps Debate| Title | PolitiCorps | Access | Comments | Views | Last Post |
|---|---|---|---|---|---|
| There are no visible public or private PolitiCorps discussions concerning the 2021 US Congress SB4152 at this time. | |||||
